openPR Logo
Press release

The Global Molecular Point Of Care Diagnostics Market to Gain $7398.82 Million by 2028

05-29-2020 02:09 PM CET | Health & Medicine

Press release from: Triton Market Research

Global Molecular Point Of Care Diagnostics Market

Global Molecular Point Of Care Diagnostics Market

A Triton Market Research report on the global molecular point of care diagnostics market, has determined that the industry, which generated $2004.43 million in 2018, is expected to flourish with a CAGR of 14.05% by 2028.

A study by Triton Market Research with the title 'Global Molecular Point of Care Diagnostics Market,' covers the Global Analysis and Forecast for 2019-2028 by Application (Prenatal, Oncology, Infectious disease [Hospital-acquired Infections, Respiratory, Gastrointestinal infections, Sexually Transmitted Infections], Others), by Technology (Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction [Digital PCR, Real-time PCR], Other), by End-user (Hospital, Clinics, Diagnostic Centers, Others), and by Geographical Region (Asia-Pacific, Europe, Latin America, North America, Middle East and Africa).

Molecular point of care diagnostics refers to a process of assessing a patient's health by detecting the genetic signatures in DNA or RNA. It is used for diagnosing multiple defects at a molecular level.

Request Free Sample of the Global Molecular Point of Care Diagnostics Market Report @ https://www.tritonmarketresearch.com/reports/molecular-point-of-care-diagnostics-market#request-free-sample

As per the report, the global molecular point of care diagnostics market will gain $7398.82 million by 2028, proliferating with a CAGR of 14.05% in the forecasted period 2019-2028. The increasing demand for diagnostic tests like non-invasive prenatal testing and liquid biopsy is driving the growth of the global molecular point of care diagnostics market. The rising havoc created by the spread of coronavirus has led to a sudden increase in the demand for the diagnostic technologies. This, along with the rising number of diseases, is driving the global market growth. However, the high-cost investment and infrastructure requirement are restraining the molecular point of care diagnostics market.

Based on application, the molecular point of care diagnostics market is divided into four parts - prenatal, oncology, infectious disease and others. Within the infectious disease, the market is further sub-segmented into hospital-acquired infection, respiratory, gastrointestinal infections and sexually transmitted infections. According to technology, the market is segmented into two parts, isothermal nucleic acid amplification technology and polymerase chain reaction molecular. Of these, the latter is further divided into digital PCR and real-time PCR.

Considering the geographical landscape, Asia-Pacific is likely to be the fastest-growing region for the molecular point of care diagnostics market in the forecasted years. The collaboration of the pharmaceutical industry, regulatory authorities, diagnostic companies and service providers to create a harmonized international platform in the region.

On the other hand, North America is anticipated to be the largest molecular point of care diagnostics market, contributing the highest to the overall revenue. The development of molecular diagnostics tests based on advanced biomarkers is one of the important factors driving the regional market growth.

Some of the eminent firms in the global molecular point of care diagnostics market are Abacus Diagnostica, Biomerieux SA, Luminex Corporation, Abbott, QuantuMDx Group Ltd, Quidel Corporation., Mesa Biotech, DiaSorin SpA, Danaher, Bio- Rad Laboratories Inc, Qiagen, Hologic Inc, Biocartis, F Hoffmann-La Roche Ltd and Spartan Biosciences Inc.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/molecular-point-of-care-diagnostics-market#purchase-option

Question & Answer: Molecular Point of Care Diagnostics Market

Question 1: What is driving the growth of the global molecular point of care diagnostics market?
Answer: The increasing demand for diagnostic tests like non-invasive prenatal testing and liquid biopsy is driving the growth of the global molecular point of care diagnostics market. The rising havoc created by the spread of coronavirus has lead to a sudden increase in the demand for the diagnosis technologies. This, along with the rising number of diseases, is driving the global market growth.

Question 2: Which factors are restraining the growth of the molecular point of care diagnostics market?
Answer: The high-cost investment and infrastructure requirement are restraining the growth of the molecular point of care diagnostics market.

Question 3: How are Asia-Pacific and North America impacting the molecular point of care diagnostics market outlook?
Answer: Considering the regional landscape, Asia-Pacific is likely to be the fastest-growing region for the molecular point of care diagnostics market in the forecasted years. The collaboration of the pharmaceutical industry, regulatory authorities, diagnostic companies and service providers to create a harmonized international platform in the region.

On the other hand, North America is anticipated to be the largest molecular point of care diagnostics market, contributing the highest to the overall revenue. The development of molecular diagnostics tests based on advanced biomarkers is one of the important factors driving the regional market growth.

Question 4: Which are the eminent firms in the global molecular point of care diagnostics market?
Answer: Some of the eminent firms in the global molecular point of care diagnostics market are Abacus Diagnostica, Biomerieux SA, Luminex Corporation, Abbott, QuantuMDx Group Ltd, Quidel Corporation., Mesa Biotech, DiaSorin SpA, Danaher, Bio-Rad Laboratories Inc, Qiagen, Hologic Inc, Biocartis, F Hoffmann-La Roche Ltd and Spartan Biosciences Inc.

Related Report:
Global Protein Sequencing Market

The global protein sequencing market is anticipated to reap a growth of $8970.37 million by 2028, growing with a CAGR of 6.78% during the estimated period 2019-2028.

The growing emphasis on innovative drug developments like target-based drugs is likely to aid the growth of the global protein sequencing market. Protein sequencing was primarily adopted only by large pharmaceutical and biotechnological companies; but currently, these technologies are accessible in academic research institutions as well. This may lead to the advent of the next generation of modern drug designers, which is likely to influence the market growth positively.

In addition, the emergence of technologically advanced mass spectrometry, also known as data independent analysis and hyper reaction monitoring, in the field of protein sequencing is driving the global market growth. The computational proteomics is still in its nascent phase. However, the development of this potential segment will create lucrative opportunities in the drug discovery space, thereby expanding the scope of the protein sequencing market in the coming years.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Molecular Point Of Care Diagnostics Market to Gain $7398.82 Million by 2028 here

News-ID: 2062029 • Views: 311

More Releases from Triton Market Research

Global Flexible Packaging Market Estimated to Gain $350.17 Billion in Revenue by …
A recent study by Triton Market Research titled Global Flexible Packaging Market discusses the Global Analysis and Forecasts by Type (Gusseted Bags, Stand-Up Pouches, Wraps, Flat Pouches, Rollstock, Wicketed Bags), Application (Cosmetics, Pharmaceuticals, Food & Beverage, Others), Printing Technology (Rotogravure, Digital Printing, Flexography, Others), Raw Material (Bioplastic, Aluminum, Paper, Plastic), and Geography (Latin America, Europe, Asia-Pacific, Middle East and Africa, and North America). Flexible packaging is a customization solution used for
Global Smoke Detector Market Estimated to Gain $2783.82 Million by 2028
A recent study by Triton Market Research titled 'Global Smoke Detector Market,' consists of the Global Analysis and Forecasts by End-user (Telecommunication, Manufacturing, Automotive, Commercial, Oil & Gas, Residential, Other End-users), Type (Dual Sensor, Photoelectric, Ionization, Other Types), Power Source (Hardwired Smoke Detectors, Battery-powered Smoke Detectors, Others {Hardwired with Battery}), and Regional Outlook (Europe, Latin America, Asia-Pacific North America, and Middle East and Africa). Request Free Sample of the Global Smoke
Global Renewable Methanol Market Evaluated to Grow at $4296.33 Million by 2028
A recent study by Triton Market Research titled 'Global Renewable Methanol Market' by End-user (Transportation, Power Generation, Chemical, Other End-users), Feedstock (Agricultural Waste, Forestry Residues, CO2 Emissions, Municipal Solid Waste, Other Feedstocks), Application (Solvents, DME & MTBE, Formaldehyde, Gasoline, Other Applications), and Geography (Latin America, North America Asia-Pacific, Europe, Middle East and Africa). Renewable methanol is a liquid produced from renewable energy and is used largely as a substitute for
Electric Power Distribution Automation Systems Market Analysis for 2028
According to Triton's report, the global electric power distribution automation systems market, which attained $30053.37 million in 2021, is expected to register progress at 7.05% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Electric Power Distribution Automation Systems Market' by Implementation (Feeder Automation, Substation Automation, Consumer Automation), End-user (Industrial, Commercial, Residential), and Regional Outlook (Europe, the Middle East and Africa, Asia-Pacific, North America, and Latin America).

All 5 Releases


More Releases for Diagnostic

Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Global Dermatology Diagnostic Devices Market
https://www.qandqmarketresearch.com/report-sample/dermatology-diagnostic-devices-market-6 This report studies the global Dermatology Diagnostic Devices market status and forecast, categorizes the global Dermatology Diagnostic Devices market size value & volume by key players, type, application, and region. This report focuses on the top players in North America, Europe, AsiaPacific, South America, and Middle East & Africa. Dermatology diagnostic devices are used for treating and diagnosing skin disorders. These devices assist in early detection of skin disorders and improving
Cervical Cancer Diagnostic Tests Market
A new market research report has been recently published by Transparency Market Research, a global market intelligence firm, and made available on the company website. The research study talks about the current scenario of global cervical cancer diagnosis tests market, along with the growth prospects of the market. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”
Diagnostic Catheters Market 2017-2021
The latest industry research report on  Diagnostic Catheters by MRC provides a thorough analysis of the global  Diagnostic Catheters market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the  Diagnostic Catheters industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain structure. It features qualitative and quantitative